Could you help people with relapsing MS make the treatment choice that’s right for them?
This autumn the MS Trust is launching a new, fully updated version of MS Decisions.
MS Decisions is the independent, interactive resource that helps you learn about MS disease modifying drugs, weigh up your treatment options, get more from your discussions with your MS team and make the choice that works for you.
The website was originally launched in 2004, and since then more than 100,000 people have used it to help them choose their treatment option. But in recent years a much wider range of drugs for relapsing remitting MS have become available, so deciding which one is best for you has got much more complicated.
That’s why we’re updating MS Decisions to include all the new treatments, and also making it more user friendly, so you can compare drugs side by side, and weigh up their respective pros and cons.
But we need your help to show why this resource is needed and to reach even more people who might find it useful.
If you were diagnosed with MS in the last five years, and could share your experience of choosing treatment options in this short survey, you could help us help even more people make these decisions in future.
Please fill out our short survey and help us help more people with MS make the choice that works for them.


MS won’t stop me showjumping
18 February 2019
When Laura Goodall was diagnosed with MS in 2015, she thought her showjumping days might be over. But, four years later, Laura is back competing across the country and has recently been accepted onto the British Showjumping Para team.


MS won’t stop me showjumping
18 February 2019
When Laura Goodall was diagnosed with MS in 2015, she thought her showjumping days might be over. But, four years later, Laura is back competing across the country and has recently been accepted onto the British Showjumping Para team.


MS in the Media
15 February 2019
- People with MS have poorer social cognition
- Carer strain increases with disability

Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.